These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 722712)

  • 1. Cholecystokinin (pancreozymin). 4. Synthesis and properties of a biologically active analogue of the C-terminal heptapeptide with epsilon-hydroxynorleucine sulfate replacing tyrosine sulfate.
    Bodanszky M; Martinez J; Priestley GP; Gardner JD; Mutt V
    J Med Chem; 1978 Oct; 21(10):1030-5. PubMed ID: 722712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin (pancreozymin). 3. Synthesis and properties of an analogue of the C-terminal heptapeptide with serine sulfate replacing tyrosine sulfate.
    Bodanszky M; Natarajan S; Hahne W; Gardner JD
    J Med Chem; 1977 Aug; 20(8):1047-50. PubMed ID: 894673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin (pancreozymin). Synthesis and properties of the N alpha-acetyl-derivative of cholecystokinin 27-33.
    Bodanszky M; Tolle JC; Gardner JD; Walker MD; Mutt V
    Int J Pept Protein Res; 1980 Nov; 16(5):402-11. PubMed ID: 6163740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin (pancreozymin). 5. Hormonally active desamino derivative of Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2.
    Bodanszky M; Martinez J; Walker M; Gardner JD; Mutt V
    J Med Chem; 1980 Jan; 23(1):82-5. PubMed ID: 6153722
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and some pharmacological properties of Z-Tyr(SO3H)-Met-Gly-Trp-Met-Asp(Phe-NH2)-OH, a 32-beta-aspartyl analogue of cholecystokinin (pancreozymin) 27-33.
    Martinez J; Winternitz F; Bodanszky M; Gardner JD; Walker MD; Mutt V
    J Med Chem; 1982 May; 25(5):589-93. PubMed ID: 6177857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin.
    Rodriguez M; Galas MC; Lignon MF; Mendre C; Laur J; Aumelas A; Martinez J
    J Med Chem; 1989 Oct; 32(10):2331-9. PubMed ID: 2477546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syntheses and biological activities of methoxinine-analogues of the C-terminal octapeptide of cholecystokinin-pancreozymin.
    Gillessen D; Trzeciak A; Müller RK; Studer RO
    Int J Pept Protein Res; 1979 Feb; 13(2):130-6. PubMed ID: 429089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinic activity of N alpha-hydroxysulfonyl-[Nle28,31]CCK26-33 analogues modified at the C-terminal residue.
    Sugg EE; Serra M; Shook JE; Yamamura HI; Burks TF; Korc M; Hruby VJ
    Int J Pept Protein Res; 1988 Jun; 31(6):514-9. PubMed ID: 2457563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of the amino acid in position 27 of cholecystokinin in determining its biological activity on pancreatic acini.
    Gardner JD; Walker MD; Martinez J; Priestly GP; Natarajan S; Bodanszky M
    Biochim Biophys Acta; 1980 Jul; 630(3):323-9. PubMed ID: 6156709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cholecystokinin-pancreozymin synthesis. Synthesis of [28-threonine,31-norleucine]- and [28-threonine,31-leucine]cholecystokinin-pancreozymin-(25-33)-nonapeptide].
    Moroder L; Wilschowitz L; Gemeiner M; Göhring W; Knof S; Scharf R; Thamm P; Gardner JD; Solomon TE; Wünsch E
    Hoppe Seylers Z Physiol Chem; 1981 Jul; 362(7):929-42. PubMed ID: 7275014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective modification of the ability of cholecystokinin to cause residual stimulation of pancreatic enzyme secretion.
    Villanueva ML; Martinez J; Bodanszky M; Collins SM; Jensen RT; Gardner JD
    Am J Physiol; 1982 Sep; 243(3):G214-7. PubMed ID: 6180646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N alpha-carboxyacyl analogues of CCK with a substituted Gly: interaction with pancreatic and gallbladder CCK receptors.
    von Schrenck T; Müller K; Schulze C; Mirau S; Raedler A; Greten H
    Peptides; 1993; 14(6):1309-15. PubMed ID: 7510882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activities of some cholecystokinin analogues substituted in position 29 by a beta-alanine.
    Rodriguez M; Rolland M; Lignon MF; Galas MC; Laur J; Aumelas A; Martinez J
    Int J Pept Protein Res; 1989 Nov; 34(5):394-404. PubMed ID: 2482263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactivity of cholecystokinin analogues: CCK-8 is not more potent than CCK-33.
    Solomon TE; Yamada T; Elashoff J; Wood J; Beglinger C
    Am J Physiol; 1984 Jul; 247(1 Pt 1):G105-11. PubMed ID: 6204542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of CCK-tetrapeptide analogues as potent and selective CCK-A receptor agonists.
    Shiosaki K; Lin CW; Kopecka H; Craig R; Wagenaar FL; Bianchi B; Miller T; Witte D; Nadzan AM
    J Med Chem; 1990 Nov; 33(11):2950-2. PubMed ID: 1700123
    [No Abstract]   [Full Text] [Related]  

  • 16. Properties of receptors for gastrin and CCK on gastric smooth muscle cells.
    Menozzi D; Gardner JD; Jensen RT; Maton PN
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G73-9. PubMed ID: 2473654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of [27-Tyr]-cholecystokinin-pancreozymin (CCK-PZ).
    Yajima H; Mori Y; Kiso Y; Koyama K; Tobe T; Setoyama M; Adachi H; Kanno T; Saito A
    Chem Pharm Bull (Tokyo); 1976 May; 24(5):1110-3. PubMed ID: 1021264
    [No Abstract]   [Full Text] [Related]  

  • 18. N-terminal fragments of CCK-(26-33) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
    Gardner JD; Knight M; Sutliff VE; Jensen RT
    Am J Physiol; 1985 Jan; 248(1 Pt 1):G98-102. PubMed ID: 2578257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
    Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
    J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of new cholecystokinin analogues.
    Maletínská L; Lignon MF; Galas MC; Bernad N; Pírková J; Hlavácek J; Slaninová J; Martinez J
    Eur J Pharmacol; 1992 Nov; 222(2-3):233-40. PubMed ID: 1280592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.